Prevalence of autoimmune pancreatitis and other benign disorders in pancreatoduodenectomy for presumed malignancy of the pancreatic head

Digestive Diseases and Sciences

Volumn 57, Issue 9, 2012, Pages 2458-2465

  Van Heerde, M J ^a   Biermann, K ^a   Zondervan, P E ^a   Kazemier, G ^a   Van Eijck, C H J ^a   Pek, C ^a   Kuipers, E J ^a   Van Buuren, H R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Autoimmune cholangitis; Autoimmune pancreatitis; IgG4; IgG4 related systemic disease; Pancreatoduodenectomy

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNE PANCREATITIS; DIAGNOSTIC PROCEDURE; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS DISEASE; PANCREATICODUODENECTOMY; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; SURGICAL RISK;

ADULT; AGED; AUTOIMMUNE DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PANCREATITIS;

EID: 84866396324     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2191-7     Document Type: Article

References (36)

1. Eloubeidi M, Varadarajulu S, Desai S. A prospective evaluation of an algorithm incorporating routine preoperative endoscopic-guided fine needle aspiration in suspected pancreatic cancer. J Gastrointest Surg. 2007;11:813-819.
2. Sonnenberg A, Rodriguez S, Faigel D. Diagnostic ascertainment of suspicious pancreatic mass: a threshold analasys. Clin Gastroenterol Hepatol. 2008;6:1162-1166.
3. Abraham S, Wilentz R, Yeo C, et al. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all 'chronic pancreatitis'? Am J Surg Pathol. 2003;27:110-120. (Pubitemid 36014904)
4. De Castro S, de Nes L, Nio C, et al. Incidence and characteristics of chronic and lymphoplasmacytic sclerosing pancreatitis in patients scheduled to undergo a pancreatoduodenectomy. HPB. 2010;12:15-21.
5. Smith C, Behrns K, van Heerden J, Sarr M. Radical pancreatoduodenectomy for misdiagnosed pancreatic mass. Br J Surg. 1994;81:585-589. (Pubitemid 24183690)
6. Van Gulik T, Moojen T, van Geenen R, Rauws E, Obertop H, Gouma D. Differential diagnosis of focal pancreatitis and pancreatic cancer. Ann Oncol. 1999;10:85-88.
7. Cohen J, Kuchta N, Geller N. Pancreatoduodenectomy for benign disease. Ann Surg. 1983;197:68-71.
8. De la Fuente, S., Ceppa, E., Reddy, S., Clary, B., Tyler, D., Pappas, T. Incidence of benign disease in patients that underwent resection for presumed pancreatic cancer diagnosed by endoscopic ultrasonography (EUS) and fine-needle aspiration (FNA). J Gastrointest Surg. 2010. Epub. 04/28/2010.
9. Iqbal N, Lovegrove R, Tilney H. A comparison of pancreaticoduodenectomy with extended pancreaticoduodenectomy: a met-analysis of 1909 patients. Eur J Surg Oncol. 2009;35:79-86.
10. Erkelens G, Vleggaar F, Lesterhuis W, van Buuren H, van der Werf S. Sclerosing pancreato-cholangitis responsive to steroid therapy. The Lancet. 1999;354:43-44. (Pubitemid 29304304)
11. Moon S, Kim M, Park D, et al. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut. 2008;57:1704-1712.
12. Choi E, Kim M, Lee T, et al. The sensitivity and specificity of serum immunoglobin G and immunoglobin G4 levels in the diagnosis of autoimmune chronic pancreatitis: Korean experience. Pancreas. 2007;35:156-161. (Pubitemid 47075570)
13. Ghazale A, Chari S, Smyrk T, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007;102:1646-1653. (Pubitemid 47206688)
14. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732-738. (Pubitemid 32204991)
15. Hirano K, Kawabe T, Yamamoto N, et al. Serum IgG4 concentrations in pancreatic and biliary diseases. Clin Chim Acta. 2006;367:181-184.
16. Kawa S, Hamano H. Serological markers for the diagnosis of autoimmune pancreatitis. Pancreas. 2008;37:117.
17. Chari S, Smyrk T, Levy M, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010-1016. (Pubitemid 44118845)
18. Otsuki M, Chung J, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea symposium on autoimmune pancreatitis. J Gastroenterol. 2008;43:403-408. (Pubitemid 351997876)
19. Bedi M, Ghandi M, Jacob G, Lekha V, Venugopal A, Ramesh H. Ca19.9 to differentiate benign and malignant masses in chronic pancreatitis: is there any benefit? Indian J Gastroenterol. 2009;28:24-27.
20. Adsay N, Basturk O, Thirabanjasak D. Diagnostic features and differential diagnosis of autoimmune pancreatitis. Sem Diagn Pathol. 2005;22:309-317. (Pubitemid 44118645)
21. Deshpande V, Chiocca S, Finkelberg D, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol. 2006;30:1537-1545. (Pubitemid 44808790)
22. Deshpande V, Mino-Kenudson M, Brugge W, Lauwers G. Autoimmune pancreatitis: more than just a pancreatic disease? A contemporary review of its pathology. Arch Pathol Lab Med. 2005;129:1148-1154. (Pubitemid 41242428)
23. Klöppel G, Sipos B, Zamboni G, Kojima M, Morohoshi T. Autoimmune pancreatitis: histo- and immunopathological features. J Gastroenterol. 2007;42:28-31.
24. Mizukami N, Nobuhisha Y, Wada R, et al. Pancreatic malignant fibrous histiocytoma, inflammatory myofibroblastic tumor, and inflammatory pseudotumor relatated to autoimmune pancreatitis: characterisation and differential diagnosis. Virchows Arch. 2006;448:552-560. (Pubitemid 44490552)
25. Suda K, Takase M, Fukumara Y, et al. Histopathologic characteristics of autoimmune pancreatitis based on comparison with chronic pancreatitis. Pancreas. 2005;30:355-358. (Pubitemid 40586815)
26. Zamboni G, Lüttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 2004;445:552-563. (Pubitemid 40104530)
27. Zhang L, Notohara K, Levy M, Chari S, Smyrk T. IgG4-positive plasma cel infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol. 2007;20:23-28. (Pubitemid 44967946)
28. Sugumar A, Chari S. Distinguishing pancreatic cancer from autoimmune pancreatitis: a comparison of two strategies. Clin Gastroenterol Hepatol. 2009;7:S59-S62.
29. Chari S, Takahashi N, Levy M. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol. 2009;7:1097-1103.
30. Hughes D, Grobmyer S, Brennan M. Preventing pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis: cost effectiveness of IgG4. Pancreas. 2004;29:167. (Pubitemid 38971808)
31. Erdogan D, Kloek J, Ten Kate F. Immunoglobulin G4-associated sclerosing cholangitis in patients resected for presumed malignant bile duct strictures. Br J Surg. 2008;95:727-734.
32. Raina A, Krasinkas A, Greer J, et al. Serum immunoglobulin G fraction 4 levels in pancreatic cancer. Elevations not associated with autoimmune pancreatitis. Arch Pathol Lab Med. 2008;132:48-53.
33. Detlefsen S, Drewes A, Vyberg M, Klöppel G. Diagnosis of autoimmune pancreatitis by core needle biopsy: application of six microscopic criteria. Virchows Arch. 2009;454:531-539.
34. Levy M, Smyrk T, Takahashi N, Zhang L, Chari ST. Endoscopic ultrasound-guided trucut biopsy (EUS TCB) diagnosis of autoimmune pancreatitis (AIP). Abstract DDW. 2010;M1393.
35. Van der Gaag N, Rauws E, Van Eijck C. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med. 2010;362:129-137.
36. Levy M, Hammel P, Ruszniewski P. Diagnostic challenge in autoimmune pancreatitis: beware of shipwrek! Gut. 2008;57:1646-1647.